Virinder Nohria Net Worth & Insider Trades

Virinder Nohria - Director, Horizon Pharma Plc

As of May 4, 2017

What is Virinder Nohria's Net Worth?

The current estimated net worth of Horizon Pharma Plc's Director, Virinder Nohria, is estimated to be about $22.55M . Virinder Nohria owns about 195,094 units of Horizon Pharma Plc common stock. In the last 3 years at Horizon Pharma Plc, Virinder Nohria has sold an estimated value of $20.51M worth.

What is Virinder Nohria's Past Insider Trading?

Virinder Nohria's largest sale order was 1,739,130 units , worth over $20.07M on November 17, 2014. In total, Virinder Nohria has made about 7 transactions over 3 years of their time at Horizon Pharma Plc. Virinder Nohria usually trades in May, with the busiest year in 2016. The most recent transaction was a sale order of 25,000 units , worth over $442.28K on June 15, 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Virinder Nohria

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Virinder Nohria's' Mailing Address?

  • Mailing address is 1055 Powers Place, Suite B Alpharetta GA 30009 GA

Horizon Pharma Plc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Timothy P. Walbert 2020 $1,146,542 - $199,548 $199,548 $199,548 $199,548 $21,632,803
Timothy P. Walbert 2019 $1,108,700 - $226,871 $226,871 $226,871 $226,871 $13,873,172
Timothy P. Walbert 2018 $1,076,250 - $160,363 $160,363 $160,363 $160,363 $16,796,894
Paul W. Hoelscher 2020 $600,569 - $106,485 $106,485 $106,485 $106,485 $5,915,146
Paul W. Hoelscher 2019 $580,748 - $120,135 $120,135 $120,135 $120,135 $4,443,588
Paul W. Hoelscher 2018 $563,750 - $104,332 $104,332 $104,332 $104,332 $7,034,386
Andy Pasternak 2020 $669,021 $250,000 $66,872 $66,872 $66,872 $66,872 $5,826,126
Andy Pasternak 2019 $108,333 $500,000 $19,188 $19,188 $19,188 $19,188 $2,924,542
Jeffrey W. Sherman, M.D., FACP 2020 $578,731 - $92,545 $92,545 $92,545 $92,545 $5,261,300
Jeffrey W. Sherman, M.D., FACP 2019 $559,630 - $95,222 $95,222 $95,222 $95,222 $3,568,496
Jeffrey W. Sherman, M.D., FACP 2018 $543,250 - $68,263 $68,263 $68,263 $68,263 $3,678,874
Barry J. Moze 2020 $628,960 - $75,659 $75,659 $75,659 $75,659 $5,073,877
Barry J. Moze 2019 $608,201 - $58,744 $58,744 $58,744 $58,744 $4,662,510
Barry J. Moze 2018 $590,400 - $35,114 $35,114 $35,114 $35,114 $2,732,565
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492426/000119312521084225/d42343ddef14a.htm

What are Horizon Pharma Plc's Past Insider Trades?

Horizon Pharma Plc's most recent insider trade came on January 18, 2023 by Andy Pasternak who sold 27,129 units worth $3.07M . In the last 12 years, insiders at Horizon Pharma Plc have sold an estimated value of $967.93M and bought an estimated value of $122.97M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Timothy Walbert, Chairman,  Jeffrey Sherman, EVP and Chief Medical Officer,  and Paul Hoelscher, EVP .

Horizon Therapeutics Public Ltd Co Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...